Cytarabine-Induced Corneal Toxicity: Clinical Features and Relief of Symptoms with Loteprednol Etabonate 0.5% in Two Patients
We report two patients who developed toxic keratopathy following high-dose cytarabine chemotherapy and whose symptoms resolved following topical loteprednol etabonate 0.5% treatment. A 25-year-old woman and a 26-year-old man with acute myeloid leukemia were referred to our department with symptoms o...
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Turkish Ophthalmology Society
2021-04-01
|
| Series: | Türk Oftalmoloji Dergisi |
| Assuntos: | |
| Acceso en liña: |
http://www.oftalmoloji.org/archives/archive-detail/article-preview/cytarabine-nduced-corneal-toxicity-clinical-featur/47351
|
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
